Stone House Investment Management, LLC Viking Therapeutics, Inc. Transaction History
Stone House Investment Management, LLC
- $380 Million
- Q2 2024
A detailed history of Stone House Investment Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Stone House Investment Management, LLC holds 300 shares of VKTX stock, worth $19,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$19,487
Previous $24,000
37.5%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
443Shares Held
63.4MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$656 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$391 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$333 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$146 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$121 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.98B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...